Keywords: Cost analysis; Dalbavancin; Meta-analysis; Oritavancin; Systematic review;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Antimicrobial resistance; Soft tissue abscess; Intraabdominal abscess; Dalbavancin; Oritavancin; Ceftaroline fosamil; Ceftolozane-tazobactam; Ceftazidime-avibactam;
Keywords: acute bacterial skin and skin structure infections; dalbavancin; oritavancin; telavancin;
Keywords: ceftazidime/avibactam; ceftolozane/tazobactam; dalbavancin; oritavancin; tedizolid
Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014
Keywords: Oritavancin; Lipoglycopeptide; Gram-positive cocci;
In vitro activity of oritavancin against planktonic and biofilm states of vancomycin-susceptible and vancomycin-resistant enterococci
Keywords: Oritavancin; Enterococcus faecalis; Enterococcus faecium; VRE; Biofilm;
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
Keywords: Staphylococcus aureus; Tedizolid; Dalbavancin; Ceftaroline; Ceftobiprole; Oritavancin;
In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015
Keywords: Oritavancin; Glycolipopeptides; MRSA; Surveillance;
In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013
Keywords: Oritavancin; MRSA; Skin and soft tissue infection;
In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin
Keywords: Oritavancin; Susceptibility; Daptomycin nonsusceptible MRSA
Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
Keywords: Oritavancin; Therapeutic use; Glycopeptides; Gram-positive bacterial infections; Vancomycin resistance
Interactions of oritavancin, a new semi-synthetic lipoglycopeptide, with lipids extracted from Staphylococcus aureus
Keywords: Vancomycin; Oritavancin; Lipoglycopeptides; Staphylococcus aureus; POPE; POPG; Cardiolipin; lysylDOPG; Lipids; Laurdan; DPH; ANS; Calcein release; AFM
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital
Keywords: Antimicrobial activity; MRSA; Glycopeptides; Linezolid; Oritavancin; Daptomycin
Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization
Keywords: Vancomycin; Oritavancin; POPE; POPG; POPC; Cardiolipin; Calcein release; AFM; Membrane permeability
Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
Keywords: Oritavancin; Polysorbate 80; Quality control
New antibiotic agents for bloodstream infections
Keywords: Bloodstream infections; Daptomycin; Linezolid; Quinupristin/dalfopristin; Tigecycline; Dalbavancin; Telavancin; Oritavancin; Ceftobiprole; Doripenem; Colistin; Antibiotic lock therapy; Continuous intravenous antibiotic administration
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis
Keywords: Daptomycin; fusidic acid; linezolid; macrophages; oritavancin; quinupristin–dalfopristin; resistance; rifampicin; S aureus; vancomycin